VIVIMEDLAB — Vivimed Labs Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Annual cashflow statement for Vivimed Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,095 | -758 | -643 | -3,307 | -458 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 590 | 539 | 398 | 359 | 24.3 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 631 | 5,337 | 338 | 2,117 | -5.41 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 796 | 5,673 | 275 | 254 | -240 |
| Capital Expenditures | -1,128 | — | -164 | — | -20.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -832 | 4,040 | 0 | 49.7 | 303 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -1,960 | 4,040 | -164 | 49.7 | 283 |
| Financing Cash Flow Items | -590 | -539 | -398 | -359 | -24.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 724 | -10,153 | -104 | -338 | -60.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -440 | -441 | 7.53 | -34.2 | -17.4 |